US Stock Market Move | Diabetes treatment technology achieves major breakthroughs. Sana Biotechnology (SANA.US) surged more than 232%.
On Wednesday, Sana Biotechnology (SANA.US) surged over 232%, reaching $5.52.
On Wednesday, Sana Biotechnology (SANA.US) surged over 232%, reaching $5.52. In terms of news, Sana Biotechnology released positive data on its investigational treatment for Type 1 diabetes. The company stated that it transplanted its therapy, UP421, which utilizes a low-immunogenicity biological material core therapy, to a Type 1 diabetes patient who was not using any immunosuppressive drugs. The study did not find any safety issues, and the low-immunogenicity modified core therapy evaded immune reactions.
Related Articles
.png)
HK Bull/Bear Outstanding Qty Ratio(59:41) | December 27th
NVIDIA Corporation (NVDA.US) partners with Groq: The era of AI inference is approaching, the high-profit myth may face a test.
Overnight US stocks | The three major indexes fell, with the S&P 500 index hitting a new high intraday. Spot silver prices surged more than 10%.
HK Bull/Bear Outstanding Qty Ratio(59:41) | December 27th
NVIDIA Corporation (NVDA.US) partners with Groq: The era of AI inference is approaching, the high-profit myth may face a test.
Overnight US stocks | The three major indexes fell, with the S&P 500 index hitting a new high intraday. Spot silver prices surged more than 10%.
RECOMMEND
Not Just “Power Shortages,” Delays Will Become The Key Theme For U.S. Data Centers In 2026
26/12/2025
Hang Seng Index Rises 33% This Year, Best Five‑Year Performance; Multiple Institutions Forecast Breakthrough Above 30,000 Next Year
26/12/2025
Gold Rally Has Further To Run, JPMorgan Bullish: Prices Could Reach USD 5,055 By Year‑End 2026
26/12/2025
